Target intelligence / Profile preview

Ras homolog family member A (mRNA) (RHOA mRNA)

Target
RHOA mRNA
Molecular classification
Messenger RNA, Small GTPase (encoded protein family), Rho family of GTPases
01

Overview

Ras homolog family member A (RHOA) mRNA encodes a small GTPase that functions as a molecular switch, cycling between an active GTP-bound and an inactive GDP-bound state (UniProt P61586). The encoded protein is a central regulator of the actin cytoskeleton, influencing cell shape, adhesion, and motility through the activation of downstream effectors like ROCK (Rho-associated protein kinase) (NCBI Gene ID: 387). In many pathological contexts, particularly oncology, RHOA is frequently overexpressed or mutated, driving invasive and metastatic phenotypes in cancers such as diffuse-type gastric cancer and certain T-cell lymphomas (PubMed: 25132177, 24509477). Targeting the RHOA mRNA using RNA interference (RNAi) or antisense oligonucleotides (ASOs) aims to reduce the total pool of RhoA protein, thereby suppressing oncogenic signaling and restoring normal cellular architecture (PubMed: 15622165). While promising, therapeutic development faces challenges regarding the delivery of RNA-based drugs and the potential for toxicity given RhoA's fundamental role in maintaining the structural integrity of healthy cells (PubMed: 28655765).

Other names
ARH12ARHARHO12Ras homolog gene family, member A mRNATransforming protein RhoA mRNA
02

Mechanism of action

RNA interference (RNAi) or antisense-mediated degradation of mRNA to prevent the translation of the RhoA protein, thereby inhibiting downstream signaling pathways involved in cell proliferation and migration (PubMed: 15622165).

03

Biological functions

Cytoskeleton organizationCell migrationSignal transductionCell cycle regulationActin filament assembly
04

Disease associations

CancerGastric cancerBreast cancerCardiovascular diseaseFibrosisT-cell lymphoma
05

Safety considerations

Off-target effects of RNA-based therapiesSystemic toxicity due to RhoA's essential role in normal cellular processesDelivery challenges to specific tissues (PubMed: 28655765)
06

Interacting drugs

siRHOA (experimental siRNA)

1 more in the full profile.

07

Biomarkers

RHOA mRNA expression levelsRHOA protein levelsRHOA mutations (e.g., Y42C, G17V)

Beyond the preview

Go deeper on Ras homolog family member A (mRNA) (RHOA mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras homolog family member A (mRNA) (RHOA mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call